Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Malignant Solid Neoplasm × Iohexol × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Malignant Solid Neoplasm 1 Leiomyoma 1 Adenomyosis 1

Interventions

Specimen Handling 4 Biopsy 3 X-Rays 2 trastuzumab biosimilar HLX02 1 pertuzumab 1 erdafitinib 1 copanlisib 1 Trastuzumab 1 PF-05280014 1 Ontruzant 1 Ogivri 1 Magnetic Resonance Spectroscopy 1 Iohexol 1 Carboplatin 1 CT-P6 1 2C4 antibody 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03997370 2026-03-27

Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol

NRG Oncology

Phase 1 Active not recruiting

Other solid neoplasm

Malignant Solid Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon ⚡